Generation Bio (GBIO) News Today $1.19 +0.11 (+10.19%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Generation Bio Co Ordinary SharesDecember 3, 2024 | morningstar.comBaker BROS. Advisors LP Buys 737,988 Shares of Generation Bio Co. (NASDAQ:GBIO)Baker BROS. Advisors LP grew its stake in Generation Bio Co. (NASDAQ:GBIO - Free Report) by 61.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,944,945 shares of the company's stock after buying an additionalDecember 2, 2024 | marketbeat.comGeneration Bio Co. Reports Q3 2024 Financials and ProgressNovember 22, 2024 | markets.businessinsider.comGeneration Bio's SWOT analysis: innovative gene therapy stock faces timeline hurdlesNovember 15, 2024 | investing.comGeneration Bio (NASDAQ:GBIO) Stock, Option ChainNovember 11, 2024 | benzinga.comFY2024 EPS Estimates for Generation Bio Increased by WedbushGeneration Bio Co. (NASDAQ:GBIO - Free Report) - Stock analysts at Wedbush increased their FY2024 earnings per share estimates for Generation Bio in a research note issued to investors on Thursday, November 7th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per sNovember 11, 2024 | marketbeat.comEarnings Update: Generation Bio Co. (NASDAQ:GBIO) Just Reported Its Third-Quarter Results And Analysts Are Updating Their ForecastsNovember 10, 2024 | finance.yahoo.comHold Rating Maintained for Generation Bio Amid Technological Progress and Timeline UncertaintyNovember 7, 2024 | markets.businessinsider.comOptimistic Buy Rating for Generation Bio Driven by mRNA Advances and Strong Financial PositionNovember 7, 2024 | markets.businessinsider.comPromising Pipeline and Strong Financials Affirm Buy Rating for Generation BioNovember 7, 2024 | markets.businessinsider.comGeneration Bio Reports Recent Business Highlights and Third Quarter 2024 Financial ResultsNovember 7, 2024 | markets.businessinsider.comGeneration Bio: Hold Rating Due to Positive Developments and Uncertain IND TimelinesNovember 7, 2024 | markets.businessinsider.comBullish Generation Bio Insiders Loaded Up On US$778.9k Of StockOctober 31, 2024 | uk.finance.yahoo.comGeneration Bio Co. (NASDAQ:GBIO) Short Interest Down 13.4% in OctoberGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) was the recipient of a large drop in short interest in the month of October. As of October 15th, there was short interest totalling 1,740,000 shares, a drop of 13.4% from the September 30th total of 2,010,000 shares. Based on an average trading volume of 101,500 shares, the short-interest ratio is currently 17.1 days. Approximately 3.6% of the shares of the stock are sold short.October 29, 2024 | marketbeat.comNeedham & Company LLC Reiterates "Buy" Rating for Generation Bio (NASDAQ:GBIO)Needham & Company LLC reiterated a "buy" rating and issued a $10.00 price objective on shares of Generation Bio in a research note on Wednesday.October 23, 2024 | marketbeat.comGeneration Bio presents preclinical data on ctLNP and iqDNAOctober 22, 2024 | markets.businessinsider.comGeneration Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual CongressOctober 22, 2024 | globenewswire.comGeneration Bio Co. (NASDAQ:GBIO) Short Interest Down 6.1% in SeptemberGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) was the recipient of a large drop in short interest during the month of September. As of September 30th, there was short interest totalling 2,010,000 shares, a drop of 6.1% from the September 15th total of 2,140,000 shares. Based on an average trading volume of 104,700 shares, the days-to-cover ratio is currently 19.2 days. Approximately 4.1% of the company's shares are sold short.October 16, 2024 | marketbeat.comGeneration Bio Co. (GBIO)October 2, 2024 | finance.yahoo.comGeneration Bio Co. (NASDAQ:GBIO) Short Interest Up 13.8% in SeptemberGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) was the recipient of a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 2,140,000 shares, a growth of 13.8% from the August 31st total of 1,880,000 shares. Based on an average daily volume of 116,800 shares, the short-interest ratio is presently 18.3 days. Approximately 4.4% of the shares of the stock are sold short.September 29, 2024 | marketbeat.comGeneration Bio to Present at the 2024 Cantor Global Healthcare ConferenceSeptember 12, 2024 | globenewswire.comGeneration Bio (NASDAQ:GBIO) Stock Price Down 0.4%Generation Bio (NASDAQ:GBIO) Trading Down 0.4%September 6, 2024 | marketbeat.comRunway's Gen-3 Turbo AI video generator just got a big upgrade — here’s what’s newAugust 22, 2024 | msn.comQ3 2024 Earnings Forecast for Generation Bio Co. (NASDAQ:GBIO) Issued By WedbushGeneration Bio Co. (NASDAQ:GBIO - Free Report) - Equities research analysts at Wedbush reduced their Q3 2024 earnings estimates for shares of Generation Bio in a research report issued on Wednesday, August 7th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings ofAugust 12, 2024 | marketbeat.comGeneration Bio Co. (NASDAQ:GBIO) Reported Earnings Last Week And Analysts Are Already Upgrading Their EstimatesAugust 10, 2024 | finance.yahoo.comBuy Rating Affirmed for Generation Bio on Strong Financials and Technological AdvancementsAugust 9, 2024 | markets.businessinsider.comGeneration Bio's (GBIO) "Outperform" Rating Reaffirmed at WedbushWedbush reiterated an "outperform" rating and issued a $5.00 target price on shares of Generation Bio in a research report on Thursday.August 8, 2024 | marketbeat.comThe bra trend Gen Z are ditching fast — and it’s not what you thinkAugust 7, 2024 | nypost.comGeneration Bio Reports Second Quarter 2024 Financial ResultsAugust 7, 2024 | finance.yahoo.comGeneration Bio to Present at the Canaccord Genuity 44th Annual Growth ConferenceAugust 6, 2024 | globenewswire.comCompanies Like Generation Bio (NASDAQ:GBIO) Are In A Position To Invest In GrowthAugust 3, 2024 | finance.yahoo.comPrice T Rowe Associates Inc. MD Boosts Stock Position in Generation Bio Co. (NASDAQ:GBIO)Price T Rowe Associates Inc. MD lifted its holdings in Generation Bio Co. (NASDAQ:GBIO - Free Report) by 28.2% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 8,878,361 shares of the company's stock after purchasing an addAugust 1, 2024 | marketbeat.comGen Z parents have amazing sex, new study reveals — millennials, not so muchJuly 31, 2024 | nypost.comGeneration Bio Co. (NASDAQ:GBIO) Shares Bought by Bellevue Group AGBellevue Group AG grew its position in Generation Bio Co. (NASDAQ:GBIO - Free Report) by 6.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,861,575 shares of the company's stock after purchasing an addiJuly 28, 2024 | marketbeat.comAcadian Asset Management LLC Raises Position in Generation Bio Co. (NASDAQ:GBIO)Acadian Asset Management LLC raised its stake in shares of Generation Bio Co. (NASDAQ:GBIO - Free Report) by 113.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 479,835 shares of the company'sJuly 25, 2024 | marketbeat.comWilson Sossion says Gen Zs are product of Mwai Kibaki's free education: "Highly informed"July 24, 2024 | msn.comGeneration Bio Co. (NASDAQ:GBIO) Short Interest Up 10.5% in JuneGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) saw a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 1,680,000 shares, a growth of 10.5% from the June 15th total of 1,520,000 shares. Based on an average daily volume of 172,900 shares, the days-to-cover ratio is currently 9.7 days. Approximately 3.5% of the shares of the company are sold short.July 16, 2024 | marketbeat.comGeneration Bio Co. (NASDAQ:GBIO) Receives Average Rating of "Hold" from AnalystsGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) has been given a consensus recommendation of "Hold" by the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and two have given a buy recJuly 10, 2024 | marketbeat.comGeneration Bio Co. (NASDAQ:GBIO) COO Antoinette Paone Sells 6,719 SharesJuly 6, 2024 | insidertrades.comGeneration Bio Co. (NASDAQ:GBIO) COO Sells $18,410.06 in StockGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) COO Antoinette Paone sold 6,719 shares of the business's stock in a transaction dated Monday, July 1st. The stock was sold at an average price of $2.74, for a total value of $18,410.06. Following the transaction, the chief operating officer now directly owns 13,807 shares of the company's stock, valued at approximately $37,831.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.July 3, 2024 | marketbeat.comGeneration Bio Co. (NASDAQ:GBIO) Given Consensus Rating of "Hold" by BrokeragesGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) has been given an average recommendation of "Hold" by the six ratings firms that are covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The averageJune 15, 2024 | marketbeat.comGeneration Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA SummitJune 14, 2024 | globenewswire.comGeneration Bio Co. (NASDAQ:GBIO) Sees Significant Drop in Short InterestGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) was the target of a large drop in short interest in May. As of May 15th, there was short interest totalling 1,620,000 shares, a drop of 7.4% from the April 30th total of 1,750,000 shares. Currently, 3.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 233,800 shares, the short-interest ratio is currently 6.9 days.June 2, 2024 | marketbeat.comInsider Buyers At Generation Bio Sitting On US$1.1m ProfitMay 22, 2024 | finance.yahoo.comShort Interest in Generation Bio Co. (NASDAQ:GBIO) Grows By 10.8%Generation Bio Co. (NASDAQ:GBIO - Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 1,750,000 shares, a growth of 10.8% from the April 15th total of 1,580,000 shares. Based on an average trading volume of 243,500 shares, the short-interest ratio is currently 7.2 days. Currently, 3.6% of the shares of the stock are sold short.May 17, 2024 | marketbeat.comGeneration Bio Co. (NASDAQ:GBIO) Expected to Earn Q2 2024 Earnings of ($0.21) Per ShareGeneration Bio Co. (NASDAQ:GBIO - Free Report) - Wedbush upped their Q2 2024 earnings per share (EPS) estimates for shares of Generation Bio in a research note issued to investors on Tuesday, May 14th. Wedbush analyst D. Nierengarten now forecasts that the company will earn ($0.21) per share forMay 16, 2024 | marketbeat.comGeneration Bio Co. Expected to Earn Q1 2025 Earnings of ($0.12) Per Share (NASDAQ:GBIO)Generation Bio Co. (NASDAQ:GBIO - Free Report) - Research analysts at Wedbush issued their Q1 2025 earnings per share estimates for shares of Generation Bio in a research report issued on Tuesday, May 14th. Wedbush analyst D. Nierengarten anticipates that the company will post earnings per shareMay 15, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO) and Generation Bio (GBIO)May 14, 2024 | markets.businessinsider.comGeneration Bio (NASDAQ:GBIO) Earns "Buy" Rating from Needham & Company LLCNeedham & Company LLC restated a "buy" rating and issued a $10.00 price objective on shares of Generation Bio in a report on Tuesday.May 14, 2024 | marketbeat.comGBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q1 2024May 13, 2024 | investorplace.com Get Generation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. GBIO Media Mentions By Week GBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GBIO News Sentiment▼0.000.60▲Average Medical News Sentiment GBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GBIO Articles This Week▼01▲GBIO Articles Average Week Get Generation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CCCC News FDMT News IMMP News BNTC News CMPS News FHTX News ACIU News AMLX News LFCR News ITOS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GBIO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Generation Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Generation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
